印度的结核病：全面的SWOC分析

Q3 Medicine

Indian Journal of Tuberculosis Pub Date : 2025-07-01 DOI:10.1016/j.ijtb.2024.10.001

Ponmani P. , Ratnesh Sinha , Sayan Kumar Das

{"title":"印度的结核病：全面的SWOC分析","authors":"Ponmani P. , Ratnesh Sinha , Sayan Kumar Das","doi":"10.1016/j.ijtb.2024.10.001","DOIUrl":null,"url":null,"abstract":"<div><div>Tuberculosis (TB) is one of the major public health problems which has cursed humanity for centuries. 45 % of the global incidence of TB and 50% of global mortality due to TB is contributed by the World Health Organisation (WHO) South-East Asia (SEA) Region. India is the top contributor to TB burden in the world. In order to combat TB, India has developed and revised its health program regularly. India started its effort by launching the National Tuberculosis Control Programme (NTP) in 1962, which was gradually revised into the Revised National Tuberculosis Control Programme (RNTCP) in 1993 and now it is known as the National Tuberculosis Elimination Programme (NTEP) in 2020. In spite of the WHO's target of ending TB globally by 2035, the Indian government intends to accomplish this by 2025.</div><div>NTEP's National Strategic Plan (NSP) 2017–2025 aims to eliminate TB, by focusing on reducing TB incidence, related deaths, and out-of-pocket expenditure. NSP 2017–2025 has four pillars: Detect, Treat, Prevent, and Build. These pillars emphasise the importance of early and accurate diagnosis of TB; treatment of TB; control and spread of TB infection; and focus on community participation. Unless the NSP's strengths are not strengthened further, weaknesses are not addressed, and opportunities and challenges are not fulfilled, the goal of eradicating tuberculosis will remain a pipe dream.</div><div>Our review has focussed on the Strength – Weakness – Opportunities - Challenges (SWOC) of NTEP highlighting the efforts of the Indian Health System in combating TB.</div></div>","PeriodicalId":39346,"journal":{"name":"Indian Journal of Tuberculosis","volume":"72 3","pages":"Pages 275-281"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Tuberculosis in India: Comprehensive SWOC analysis\",\"authors\":\"Ponmani P. , Ratnesh Sinha , Sayan Kumar Das\",\"doi\":\"10.1016/j.ijtb.2024.10.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Tuberculosis (TB) is one of the major public health problems which has cursed humanity for centuries. 45 % of the global incidence of TB and 50% of global mortality due to TB is contributed by the World Health Organisation (WHO) South-East Asia (SEA) Region. India is the top contributor to TB burden in the world. In order to combat TB, India has developed and revised its health program regularly. India started its effort by launching the National Tuberculosis Control Programme (NTP) in 1962, which was gradually revised into the Revised National Tuberculosis Control Programme (RNTCP) in 1993 and now it is known as the National Tuberculosis Elimination Programme (NTEP) in 2020. In spite of the WHO's target of ending TB globally by 2035, the Indian government intends to accomplish this by 2025.</div><div>NTEP's National Strategic Plan (NSP) 2017–2025 aims to eliminate TB, by focusing on reducing TB incidence, related deaths, and out-of-pocket expenditure. NSP 2017–2025 has four pillars: Detect, Treat, Prevent, and Build. These pillars emphasise the importance of early and accurate diagnosis of TB; treatment of TB; control and spread of TB infection; and focus on community participation. Unless the NSP's strengths are not strengthened further, weaknesses are not addressed, and opportunities and challenges are not fulfilled, the goal of eradicating tuberculosis will remain a pipe dream.</div><div>Our review has focussed on the Strength – Weakness – Opportunities - Challenges (SWOC) of NTEP highlighting the efforts of the Indian Health System in combating TB.</div></div>\",\"PeriodicalId\":39346,\"journal\":{\"name\":\"Indian Journal of Tuberculosis\",\"volume\":\"72 3\",\"pages\":\"Pages 275-281\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian Journal of Tuberculosis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0019570724002294\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Tuberculosis","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0019570724002294","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

结核病（TB）是困扰人类几个世纪的主要公共卫生问题之一。全球45%的结核病发病率和50%的结核病死亡率来自世界卫生组织（世卫组织）东南亚区域。印度是世界上结核病负担的最大贡献者。为了防治结核病，印度定期制定和修订其卫生规划。印度于1962年启动了国家结核病控制规划（NTP），该规划于1993年逐步修订为修订后的国家结核病控制规划（RNTCP），现在被称为2020年的国家结核病消除规划（NTEP）。尽管世界卫生组织的目标是到2035年在全球终结结核病，但印度政府打算到2025年实现这一目标。NTEP的2017-2025年国家战略计划（NSP）旨在通过重点减少结核病发病率、相关死亡和自费支出来消除结核病。NSP 2017-2025有四大支柱：检测、治疗、预防和建设。这些支柱强调早期和准确诊断结核病的重要性；结核病治疗；结核感染的控制和传播；注重社区参与。除非国家战略的优势得不到进一步加强，弱点得不到解决，机遇和挑战得不到满足，否则根除结核病的目标仍将是一个白日梦。我们的审查侧重于NTEP的优势-劣势-机遇-挑战（SWOC），突出了印度卫生系统在抗击结核病方面的努力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Tuberculosis in India: Comprehensive SWOC analysis

Tuberculosis (TB) is one of the major public health problems which has cursed humanity for centuries. 45 % of the global incidence of TB and 50% of global mortality due to TB is contributed by the World Health Organisation (WHO) South-East Asia (SEA) Region. India is the top contributor to TB burden in the world. In order to combat TB, India has developed and revised its health program regularly. India started its effort by launching the National Tuberculosis Control Programme (NTP) in 1962, which was gradually revised into the Revised National Tuberculosis Control Programme (RNTCP) in 1993 and now it is known as the National Tuberculosis Elimination Programme (NTEP) in 2020. In spite of the WHO's target of ending TB globally by 2035, the Indian government intends to accomplish this by 2025.

NTEP's National Strategic Plan (NSP) 2017–2025 aims to eliminate TB, by focusing on reducing TB incidence, related deaths, and out-of-pocket expenditure. NSP 2017–2025 has four pillars: Detect, Treat, Prevent, and Build. These pillars emphasise the importance of early and accurate diagnosis of TB; treatment of TB; control and spread of TB infection; and focus on community participation. Unless the NSP's strengths are not strengthened further, weaknesses are not addressed, and opportunities and challenges are not fulfilled, the goal of eradicating tuberculosis will remain a pipe dream.

Our review has focussed on the Strength – Weakness – Opportunities - Challenges (SWOC) of NTEP highlighting the efforts of the Indian Health System in combating TB.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Indian Journal of Tuberculosis Medicine-Infectious Diseases

CiteScore

2.80

自引率

0.00%

发文量

103

期刊介绍： Indian Journal of Tuberculosis (IJTB) is an international peer-reviewed journal devoted to the specialty of tuberculosis and lung diseases and is published quarterly. IJTB publishes research on clinical, epidemiological, public health and social aspects of tuberculosis. The journal accepts original research articles, viewpoints, review articles, success stories, interesting case series and case reports on patients suffering from pulmonary, extra-pulmonary tuberculosis as well as other respiratory diseases, Radiology Forum, Short Communications, Book Reviews, abstracts, letters to the editor, editorials on topics of current interest etc. The articles published in IJTB are a key source of information on research in tuberculosis. The journal is indexed in Medline